Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment
Arthur Karaulic(Institut de Recherche sur le Cancer et le Vieillissement de Nice), Gilles Pagès(Centre National de la Recherche Scientifique)
Cited by 1
Related Papers
Transcriptional regulation of the Vascular Endothelial Growth Factor gene?a concert of activating factors
|Cardiovascular Research|2004|430
The Extracellular Signal–Regulated Kinase Isoform ERK1 Is Specifically Required for In Vitro and In Vivo Adipogenesis
|Diabetes|2005|334
Identification of Two Sp1 Phosphorylation Sites for p42/p44 Mitogen-activated Protein Kinases
|Journal of Biological Chemistry|2002|290
ERK1/2/MAPK pathway-dependent regulation of the telomeric factor TRF2
|Oncotarget|2016|31
“The anti-angiogenic compound axitinib demonstrates low toxicity and anti-tumoral effects against medulloblastoma”
|bioRxiv (Cold Spring Harbor Laboratory)|2020|2